Phospholipase Cγ2 is required for basal but not oestrogen deficiency-induced bone resorption

Zsuzsanna Kertész, Dávid Gyori, Szandra Körmendi, Tünde Fekete, Katalin Kis-Tóth, Z. Jakus, Georg Schett, E. Rajnavolgyi, Csaba Dobó-Nagy, A. Mócsai

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Eur J Clin Invest 2012; 42 (1): 49-60 Background Osteoclasts play a critical role in bone resorption under basal conditions, but they also contribute to pathological bone loss during diseases including postmenopausal osteoporosis. Phospholipase Cγ2 (PLCγ2) is an important signalling molecule in diverse haematopoietic lineages. Here, we tested the role of PLCγ2 in basal and ovariectomy-induced bone resorption, as well as in in vitro osteoclast cultures using PLCγ2-deficient (PLCγ2 -/-) mice. Materials and methods The trabecular architecture of long bone metaphyses was tested by micro-CT and histomorphometric analyses. Postmenopausal osteoporosis was modelled by surgical ovariectomy. Osteoclast development and function, gene expression and PLCγ2 phosphorylation were tested on in vitro osteoclast and macrophage cultures. Results PLCγ2 -/- mice had significantly higher trabecular bone mass under basal conditions than wild-type mice. PLCγ2 was required for in vitro development and resorptive function of osteoclasts, but not for upregulation of osteoclast-specific gene expression. PLCγ2 was phosphorylated in a Src-family-dependent manner upon macrophage adhesion but not upon stimulation by M-CSF or RANKL. Surprisingly, ovariectomy-induced bone resorption in PLCγ2 -/- mice was similar to, or even more robust than, that in wild-type animals. Conclusions Our results indicate that PLCγ2 participates in bone resorption under basal conditions, likely because of its role in adhesion receptor signalling during osteoclast development. In contrast, PLCγ2 does not appear to play a major role in ovariectomy-induced bone loss. These results suggest that basal and oestrogen deficiency-induced bone resorption utilizes different signalling pathways and that PLCγ2 may not be a suitable therapeutic target in postmenopausal osteoporosis.

Original languageEnglish
Pages (from-to)49-60
Number of pages12
JournalEuropean Journal of Clinical Investigation
Volume42
Issue number1
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Phospholipases
Bone Resorption
Bone
Estrogens
Osteoclasts
Ovariectomy
Postmenopausal Osteoporosis
Macrophages
Gene expression
Bone and Bones
Gene Expression
Phosphorylation
Wild Animals
Macrophage Colony-Stimulating Factor
Cell culture
Animals
Up-Regulation
Adhesion

Keywords

  • Gene expression
  • Knockout mice
  • Osteoclasts
  • Osteoporosis
  • Phospholipase Cγ2
  • Signalling

ASJC Scopus subject areas

  • Medicine(all)
  • Clinical Biochemistry
  • Biochemistry

Cite this

Phospholipase Cγ2 is required for basal but not oestrogen deficiency-induced bone resorption. / Kertész, Zsuzsanna; Gyori, Dávid; Körmendi, Szandra; Fekete, Tünde; Kis-Tóth, Katalin; Jakus, Z.; Schett, Georg; Rajnavolgyi, E.; Dobó-Nagy, Csaba; Mócsai, A.

In: European Journal of Clinical Investigation, Vol. 42, No. 1, 01.2012, p. 49-60.

Research output: Contribution to journalArticle

Kertész, Zsuzsanna ; Gyori, Dávid ; Körmendi, Szandra ; Fekete, Tünde ; Kis-Tóth, Katalin ; Jakus, Z. ; Schett, Georg ; Rajnavolgyi, E. ; Dobó-Nagy, Csaba ; Mócsai, A. / Phospholipase Cγ2 is required for basal but not oestrogen deficiency-induced bone resorption. In: European Journal of Clinical Investigation. 2012 ; Vol. 42, No. 1. pp. 49-60.
@article{9735bfade22541cfb4c7dbf03f69615e,
title = "Phospholipase Cγ2 is required for basal but not oestrogen deficiency-induced bone resorption",
abstract = "Eur J Clin Invest 2012; 42 (1): 49-60 Background Osteoclasts play a critical role in bone resorption under basal conditions, but they also contribute to pathological bone loss during diseases including postmenopausal osteoporosis. Phospholipase Cγ2 (PLCγ2) is an important signalling molecule in diverse haematopoietic lineages. Here, we tested the role of PLCγ2 in basal and ovariectomy-induced bone resorption, as well as in in vitro osteoclast cultures using PLCγ2-deficient (PLCγ2 -/-) mice. Materials and methods The trabecular architecture of long bone metaphyses was tested by micro-CT and histomorphometric analyses. Postmenopausal osteoporosis was modelled by surgical ovariectomy. Osteoclast development and function, gene expression and PLCγ2 phosphorylation were tested on in vitro osteoclast and macrophage cultures. Results PLCγ2 -/- mice had significantly higher trabecular bone mass under basal conditions than wild-type mice. PLCγ2 was required for in vitro development and resorptive function of osteoclasts, but not for upregulation of osteoclast-specific gene expression. PLCγ2 was phosphorylated in a Src-family-dependent manner upon macrophage adhesion but not upon stimulation by M-CSF or RANKL. Surprisingly, ovariectomy-induced bone resorption in PLCγ2 -/- mice was similar to, or even more robust than, that in wild-type animals. Conclusions Our results indicate that PLCγ2 participates in bone resorption under basal conditions, likely because of its role in adhesion receptor signalling during osteoclast development. In contrast, PLCγ2 does not appear to play a major role in ovariectomy-induced bone loss. These results suggest that basal and oestrogen deficiency-induced bone resorption utilizes different signalling pathways and that PLCγ2 may not be a suitable therapeutic target in postmenopausal osteoporosis.",
keywords = "Gene expression, Knockout mice, Osteoclasts, Osteoporosis, Phospholipase Cγ2, Signalling",
author = "Zsuzsanna Kert{\'e}sz and D{\'a}vid Gyori and Szandra K{\"o}rmendi and T{\"u}nde Fekete and Katalin Kis-T{\'o}th and Z. Jakus and Georg Schett and E. Rajnavolgyi and Csaba Dob{\'o}-Nagy and A. M{\'o}csai",
year = "2012",
month = "1",
doi = "10.1111/j.1365-2362.2011.02556.x",
language = "English",
volume = "42",
pages = "49--60",
journal = "European Journal of Clinical Investigation",
issn = "0014-2972",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Phospholipase Cγ2 is required for basal but not oestrogen deficiency-induced bone resorption

AU - Kertész, Zsuzsanna

AU - Gyori, Dávid

AU - Körmendi, Szandra

AU - Fekete, Tünde

AU - Kis-Tóth, Katalin

AU - Jakus, Z.

AU - Schett, Georg

AU - Rajnavolgyi, E.

AU - Dobó-Nagy, Csaba

AU - Mócsai, A.

PY - 2012/1

Y1 - 2012/1

N2 - Eur J Clin Invest 2012; 42 (1): 49-60 Background Osteoclasts play a critical role in bone resorption under basal conditions, but they also contribute to pathological bone loss during diseases including postmenopausal osteoporosis. Phospholipase Cγ2 (PLCγ2) is an important signalling molecule in diverse haematopoietic lineages. Here, we tested the role of PLCγ2 in basal and ovariectomy-induced bone resorption, as well as in in vitro osteoclast cultures using PLCγ2-deficient (PLCγ2 -/-) mice. Materials and methods The trabecular architecture of long bone metaphyses was tested by micro-CT and histomorphometric analyses. Postmenopausal osteoporosis was modelled by surgical ovariectomy. Osteoclast development and function, gene expression and PLCγ2 phosphorylation were tested on in vitro osteoclast and macrophage cultures. Results PLCγ2 -/- mice had significantly higher trabecular bone mass under basal conditions than wild-type mice. PLCγ2 was required for in vitro development and resorptive function of osteoclasts, but not for upregulation of osteoclast-specific gene expression. PLCγ2 was phosphorylated in a Src-family-dependent manner upon macrophage adhesion but not upon stimulation by M-CSF or RANKL. Surprisingly, ovariectomy-induced bone resorption in PLCγ2 -/- mice was similar to, or even more robust than, that in wild-type animals. Conclusions Our results indicate that PLCγ2 participates in bone resorption under basal conditions, likely because of its role in adhesion receptor signalling during osteoclast development. In contrast, PLCγ2 does not appear to play a major role in ovariectomy-induced bone loss. These results suggest that basal and oestrogen deficiency-induced bone resorption utilizes different signalling pathways and that PLCγ2 may not be a suitable therapeutic target in postmenopausal osteoporosis.

AB - Eur J Clin Invest 2012; 42 (1): 49-60 Background Osteoclasts play a critical role in bone resorption under basal conditions, but they also contribute to pathological bone loss during diseases including postmenopausal osteoporosis. Phospholipase Cγ2 (PLCγ2) is an important signalling molecule in diverse haematopoietic lineages. Here, we tested the role of PLCγ2 in basal and ovariectomy-induced bone resorption, as well as in in vitro osteoclast cultures using PLCγ2-deficient (PLCγ2 -/-) mice. Materials and methods The trabecular architecture of long bone metaphyses was tested by micro-CT and histomorphometric analyses. Postmenopausal osteoporosis was modelled by surgical ovariectomy. Osteoclast development and function, gene expression and PLCγ2 phosphorylation were tested on in vitro osteoclast and macrophage cultures. Results PLCγ2 -/- mice had significantly higher trabecular bone mass under basal conditions than wild-type mice. PLCγ2 was required for in vitro development and resorptive function of osteoclasts, but not for upregulation of osteoclast-specific gene expression. PLCγ2 was phosphorylated in a Src-family-dependent manner upon macrophage adhesion but not upon stimulation by M-CSF or RANKL. Surprisingly, ovariectomy-induced bone resorption in PLCγ2 -/- mice was similar to, or even more robust than, that in wild-type animals. Conclusions Our results indicate that PLCγ2 participates in bone resorption under basal conditions, likely because of its role in adhesion receptor signalling during osteoclast development. In contrast, PLCγ2 does not appear to play a major role in ovariectomy-induced bone loss. These results suggest that basal and oestrogen deficiency-induced bone resorption utilizes different signalling pathways and that PLCγ2 may not be a suitable therapeutic target in postmenopausal osteoporosis.

KW - Gene expression

KW - Knockout mice

KW - Osteoclasts

KW - Osteoporosis

KW - Phospholipase Cγ2

KW - Signalling

UR - http://www.scopus.com/inward/record.url?scp=83155180556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83155180556&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2362.2011.02556.x

DO - 10.1111/j.1365-2362.2011.02556.x

M3 - Article

VL - 42

SP - 49

EP - 60

JO - European Journal of Clinical Investigation

JF - European Journal of Clinical Investigation

SN - 0014-2972

IS - 1

ER -